PPD in the News
The role of implementation leads in successful FSP projects
Brian Ford notes that making an FSP model work takes coordination and accountability, which is where an implementation lead can prove valuable.
PPD and Matrix Clinical Trials team on decentralized study tech
Collaboration demonstrates Thermo Fisher’s continuing commitment to advance decentralized trial solutions for customers and patients.
Paving the way to better inhaled drug delivery
Christopher Gruenloh comments on the state of play for inhaled drugs and how the pharmaceutical laboratory is evolving to accommodate new development.
Thermo Fisher announces mobile clinical research collaboration
Innovative decentralized clinical trial solution to help identify, recruit and retain trial participants.
A review of pediatric development challenges, FDA collaboration and future trends
Susan McCune discusses challenges in pediatric development, collaborations between the regulatory agencies and future trends in pediatrics.
Decentralized clinical trials bring research to the patient — In more ways than one
Tim Rich explains how decentralized clinical trials can solve numerous pain points for patients in clinical research.
Thermo Fisher says buoyant demand prompted clinical lab expansion
Bioanalytical expansion will support increasing demand across biopharma for consistent, high-quality laboratory services to accelerate drug development.
Global life sciences company to invest $97 million to expand its clinical research operations in the Richmond region
Over the next three years, Thermo Fisher expects to add nearly 150,000 square feet and more than 500 new employees.
Thermo Fisher Adding 500 Jobs in Richmond, VA-area CRO expansion
The bulk of the expansion will occur in immunochemistry and chromatography functions, as well as subsequent enhancements in biomarker and vaccine sciences.
